Daily closing price · 250 sessions
Quantitative price outlook based on available market signals. Not financial advice.
Indicators calculated from the stored daily price history.
A verified, data-driven analysis will be generated here from price action, technical indicators, fundamentals, earnings and market context.
Dedicated research sections for 2026, 2030, 2035, 2040 and 2050. Numerical targets will appear only after the long-horizon model is validated.
Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2026 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2030 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2035 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2040 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2050 research →Only stories explicitly associated with this stock are shown.
Arteris announced an expansion of its Multi-Die product portfolio to help semiconductor companies transition from monolithic SoCs to chiplet architectures for AI, HPC, and consumer electronics. The new FlexGen Multi-Die NoC IP extends on-chip network connectivity across chip boundaries, reducing PHY area, power, and I/O requirements by up to 50%. The expanded solution includes FlexGen Multi-Die, Ncore Multi-Die, Magillem integration automation, and Cycuity hardware security verification, with support from major partners including AMD, Socionext, Cadence, Synopsys, and others.
Arteris announced an expanded Multi-Die portfolio including the new FlexGen Multi-Die product to help semiconductor companies transition from monolithic SoC designs to chiplet-based architectures. The solution extends Network-on-Chip (NoC) connectivity across die boundaries while maintaining QoS and architectural flexibility, addressing data movement challenges in AI and high-performance computing systems.
Arteris announced an expanded multi-die product portfolio including the new FlexGen Multi-Die solution, enabling semiconductor manufacturers to transition from monolithic SoC designs to chiplet-based architectures while maintaining QoS and design flexibility. The solution addresses challenges in AI, HPC, and consumer electronics by seamlessly extending NoC connectivity across chip boundaries, reducing PHY area and power consumption by up to 50%.
Common questions about price, predictions, long-term forecasts, technicals and research methodology.
SNPS is currently shown at $378.47 in the latest stored market quote. The page is refreshed from the connected market-data pipeline.
US Market AI currently shows quantitative forecasts for 24H, 7D, 30D and 90D using the stored market signals. The forecasts are estimates and not guarantees.
The 2026 long-term forecast section is included as a research framework. A numerical 2026 target is shown only after a dedicated long-horizon model has produced and validated it; the current 24H–90D model is not presented as a 2026 target.
The 2030 section tracks the inputs that a validated long-horizon model should use, including company growth, valuation, earnings, market regime and sector conditions. No unsupported price target is displayed.
The 2035, 2040 and 2050 sections are reserved for long-term model outputs. US Market AI does not invent numerical targets when validated long-horizon data is unavailable.
The page can display RSI, MACD, SMA 50, SMA 200, EMA 20, ATR, ADX, volatility, Bollinger levels, stochastic, support and resistance from stored daily price history.
Fundamental data is not currently populated for this stock, so the page does not estimate or fabricate missing values.
The latest ticker-linked news appears in the Market News section of this page. Stories are shown with source, publication date and sentiment when available.
There is not yet enough mature evaluation data on this page to claim a verified accuracy rate.
No. US Market AI provides research and model estimates for informational purposes. Forecasts can be wrong and should not be treated as personalized financial advice.
US Market AI combines quantitative signals and verified market data to support research. Forecasts are estimates, can be wrong, and are not financial advice.